Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Mechanisms underlying direct actions of hyperlipidemia on myocardium: an updated review
Yu Si Yao1, Tu Di Li1, Zhi Huan Zeng2
1Department of Cardiovascular Diseases, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, 510080, People's Republic of China.
Insights
High cholesterol (hyperlipidemia) directly harms heart function and increases heart failure risk. Lowering lipids can reverse cardiac dysfunction, offering protective strategies for patients.
Area of Science:
- Cardiology
- Metabolic Disorders
- Molecular Biology
Background:
- Hyperlipidemia is a significant risk factor for cardiovascular disease.
- It is linked to increased non-ischemic heart failure and cardiac dysfunction.
- Direct cardiac effects of hyperlipidemia, beyond atherosclerosis, are not fully understood.
Purpose of the Study:
- To review mechanisms of hyperlipidemia's direct impact on cardiac function.
- To explore the relationship between serum lipids and heart failure.
- To summarize the cardioprotective effects of lipid-lowering therapies.
Main Methods:
- Review of recent experimental and clinical studies.
- Analysis of mechanisms involving cardiac lipid accumulation, oxidative stress, inflammation, and mitochondrial dysfunction.
- Synthesis of data on lipid-lowering drug efficacy.
Main Results:
- Hyperlipidemia directly impairs systolic function and cardiac electrophysiology.
- Cardiac lipid accumulation contributes to oxidative stress and inflammation.
- Lipid reduction shows potential for reversing heart dysfunction.
Conclusions:
- Understanding direct cardiac effects of hyperlipidemia is crucial.
- Lipid management is key for preventing and treating heart failure.
- Targeting lipid pathways offers promising cardioprotective strategies for hyperlipidemic patients.
Abstract:
Hyperlipidemia is a common metabolic disorder and one of risk factors for cardiovascular disease. Clinical studies have shown that hyperlipidemia increases the risk of non-ischemic heart failure, while decreasing serum lipids can reverse heart dysfunction. Apart from indirectly affecting the function of the heart by promoting the development of atherosclerosis, hyperlipidemia also affects the systolic function and cardiac electrophysiological response of the heart directly, which may be related to gradual accumulation of cardiac lipids and consequent systemic oxidative stress, proinflammatory state and mitochondrial dysfunction. However, the mechanism underlying direct effects of hyperlipidemia on the heart are not fully understood. In this review, we provide an updated summary of recent experimental and clinical studies that focus on elucidating the mechanisms of the action of hyperlipidemia on cardiac function, the relationship between heart failure and serum lipids, and protective effects of lipid-lowering drugs on the heart. The exciting progress in this field supports the prospect of guiding early protection of the heart to benefit the patients with chronic hyperlipidemia and familial hyperlipidemia.
More Related Videos
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Myocarditis I: Introduction
Coronary Artery Disease I: Introduction
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management